Prospects for plasma protein products in China

Abstract

Plasma protein products, essential drugs for various clinical diseases, are therapeutic biological products extracted from healthy human plasma. The research and development of new plasma protein products, led by United States and European, has been widely deepened and enhanced. Therefore, accelerating the development of new plasma protein products in China is of great significance. This review summarizes the research and development of plasma protein products that have been marketed abroad but have not produced in China, as well as analyzes the difficulties and prospects of the development of plasma protein products in China.

Keywords

• plasma protein products
• immunoglobulin
• von willebrand factor complex
• anti-inhibitor coagulant complex
• human antithrombin ⅲ
• c1 esterase inhibitor